All the below times are given in CEST/UTC+2

Basic Science Workshop 1: HPV Viral Entry, Replication and Trafficking: 10:25
Basic Science Workshop 2: HPV Genera and Associated Diseases: 12:35
Basic Science Workshop 3: New Technologies: 14:55

Clinical Science Workshop 1: Cervix: Screening and Management: 10:45
Clinical Science Workshop 2: Screening and Management in Non-cervical Disease: 12:25
Clinical Science Workshop 3: Communication Skills: 14:55

Public Health Workshop 1: HPV Vaccine: 10:05
Public Health Workshop 2: Screening / Treatment: 12:25
Public Health Workshop 3: Communications Issues in Optimizing HPV Prevention Strategies: 14:55

Interdisciplinary Workshop 1: Virus: 10:45
Interdisciplinary Workshop 2: Burden of Disease: 12:25
Interdisciplinary Workshop 3: Detection and Screening: 14:55
Interdisciplinary Workshop 4: Vaccination: 16:55

All the below times are given in CEST/UTC+2

Basic Science Oral Session 1: Virus and Host Interactions: 14:45
Basic Science Oral Session 2: Transformation and Carcinogenesis: 15:50

Clinical Science Oral Session 1: Methylation Potential Use for Clinical Practice: 14:45
Clinical Science Oral Session 2: Cervical/Anal Screening and Management: 15:50

Public Health Oral Session 1: MODELLING I. Modelling and economic analyses for cervical cancer elimination: 14:45
Public Health Oral Session 2: VACCINATION I. Impact and effectiveness: 16:00

Plenary – IPVC Opening Plenary Session 20:00

All the below times are given in CEST/UTC+2

Dedicated Symposium Head and Neck Workshop: 10:00

Basic Science Oral Session 3: Adaptative and Non-adaptative Immunology: 08:35
Basic Science Oral Session 4: Vaccines and New Treatment Approaches: 10:15

Clinical Science Oral Session 3: Clinical Aspects of Cervical Prevention and Treatment: 08:35
Clinical Science Oral Session 4: Triage Approaches for HPV-Positive Women: 10:00
Clinical Science Oral Session 5: Vaccines and Screening in HPV-related disease: 12:50
Clinical Science Oral Session 6: Progression, Prognostic factors and Treatment in HPV-related disease: 14:40

Public Health Oral Session 3: SCREENING I. Artificial intelligence approaches in cervical cancer screening: 08:35
Public Health Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening: 09:45
Public Health Oral Session 5: VACCINATION II. Implementation, dissemination, and communication: 10:10
Public Health Oral Session 6: SCREENING III. Implementation, dissemination, and communication : 13:15
Public Health Oral Session 7: VACCINATION III. Implementation, dissemination, and communication: 13:00
Public Health Oral Session 8: SCREENING IV. Implementation, dissemination, and communication : 14:55

All the below times are given in CEST/UTC+2

Public Health Indigenous Peoples And HPV: Moving the Agenda Forward: 08:30

Dedicated Symposium HPV testing in low- and middle income countries: 11:45

COVID AND HPV: 15:45

Basic Science Oral Session 5: Other Anatomical Sites and Diseases: 08:30
Basic Science Oral Session 6: Animal and In Vitro Models: 10:00

Clinical Science Oral Session 7: Oropharyngeal Cancer – Biomarkers for Diagnosis and Prognosis: 08:10
Clinical Science Oral Session 8: Screening and Management Cervix Lesions: 09:20
Clinical Science Oral Session 9: Biomarkers Cervix and Other Sites: 13:45

Public Health Oral Session 9: VACCINATION IV. Strategies and schedules: 08:20
Public Health Oral Session 10: HIV. Natural history and prevention in HIV-infected People: 08:30
Public Health Oral Session 11: MODELLING II. Modelling and economic analyses for cervical cancer elimination: 09:55
Public Health Oral Session 12: EPIDEMIOLOGY I. Natural history and risk factors: 09:55
Public Health Oral Session 13: SCREENING V. Evaluation and Impact of cervical cancer screening: 14:20
Public Health Oral Session 14: SCREENING VI. Evaluation and Impact of cervical cancer screening: 14:20

All the below times are given in CEST/UTC+2

Plenary – IPVC Plenary Session 4: 12:05

Dedicated Symposium Elimination: 10:05
Dedicated Symposium Global Supply, Demand, and Pricing for HPV Vaccines and HPV Testing: 15:20
Dedicated Symposium Eliminating HPV-Caused Cancers and Diseases in Europe: A new campaign by the European Cancer Organisation: 15:55

Basic Science Oral Session 7: Host Genomics and Viral Gene Regulation: 13:40

Clinical Science Oral Session 10: Vaccines Clinical Aspects: 14:05
Clinical Science Oral Session 11: Self Sampling: 17:00

Public Health Oral Session 15: VACCINATION V. Impact and effectiveness: 10:00
Public Health Oral Session 16: EPIDEMIOLOGY II. Burden, natural history and risk factors : 13:50
Public Health Oral Session 17: HEAD & NECK CANCERS. Epidemiology, natural history and prevention: 15:15
Public Health Oral Session 18: VACCINATION AND SCREENING. Impact of HPV vaccination on cervical cancer screening: 17:40